search
Back to results

IVF Versus Surgery for Endometriosis Related Infertility (SVIDOE)

Primary Purpose

Endometriosis

Status
Recruiting
Phase
Not Applicable
Locations
Italy
Study Type
Interventional
Intervention
Surgery
IVF
Sponsored by
Fondazione IRCCS Ca' Granda, Ospedale Maggiore Policlinico
About
Eligibility
Locations
Arms
Outcomes
Full info

About this trial

This is an interventional treatment trial for Endometriosis focused on measuring IVF, surgery, endometriosis

Eligibility Criteria

18 Years - 39 Years (Adult)FemaleDoes not accept healthy volunteers

Inclusion Criteria:

  • Age < 40 years
  • Pregnancy seeking for more than 12 months
  • Regular menstrual cycle, i.e. mean cycle interval between 21 and 35 days
  • Ultrasonographic diagnosis of ovarian endometriomas or deep peritoneal endometriosis.
  • Normal seminal analysis based on WHO criteria
  • Absence of ureteral stenosis or intestinal subocclusive symptoms

Exclusion Criteria:

  • Previous surgery for endometriosis
  • Previous IVF cycles
  • Contraindication to pregnancy
  • Hydrosalpinx
  • Endometriomas with a mean diameter > 4 cm
  • Submucosal fibroids or large intramural or subserosal fibroids (≥ 5 cm).
  • Doubtful sonographic findings that do not allow to reliably rule out malignancy.
  • Obstacles to regular sexual intercourses (sexual disturbances or logistic problems)

Sites / Locations

  • ASST-FBF-Sacco, Presidio Ospedaliero Macedonio MelloniRecruiting
  • IRCCS San RaffaeleRecruiting
  • Fondazione IRCCS Ca' Granda Ospedale Maggiore PoliclinicoRecruiting

Arms of the Study

Arm 1

Arm 2

Arm Type

Active Comparator

Active Comparator

Arm Label

Surgery

In Vitro Fertilization

Arm Description

Patients undergoing surgery for endometriosis, after surgery, will receive indications for seeking for a natural pregnancy up to 12 months from the time of randomization

Patients included in the IVF arm will undergo three complete cycles of IVF (i.e. three oocytes retrievals regardless of the number of embryo transfers)

Outcomes

Primary Outcome Measures

Live birth rate from pregnancies started within 12 months since randomization
to assess whether IVF is more effective than surgery in obtaining a live birth and, if so, what is the magnitude of this benefit

Secondary Outcome Measures

Cost-effectiveness evaluation of the two different approaches in the treatment of endometriosis
to assess whether or not IVF is more cost-effective than surgery. To this aim, costs will be calculated based on the local charges for treatments (Diagnostic-related groups) and the costs of drugs supported by the public health system. The perspective will be the one of the public health provider.
Detachment of inflammatory mediators that might interfere with IVF through analysis of extracellular vescicles (EV).
to understand whether the endometriosis-related systemic inflammatory milieu demonstrated by the presence of circulating EVs characterized by an inflammatory signature may influence the folliculogenesis quality and IVF outcomes. EVs will be assessed by: Nanoparticle Tracking analysis (NTA) to determine their total values and their distribution; specific markers for the various lymphocyte populations by flow cytometry to assess the immunological origin; miRNA profile and proteomic analysis.

Full Information

First Posted
February 2, 2021
Last Updated
March 29, 2022
Sponsor
Fondazione IRCCS Ca' Granda, Ospedale Maggiore Policlinico
Collaborators
IRCCS San Raffaele, ASST Fatebenefratelli Sacco, Ministero della Salute, Italy
search

1. Study Identification

Unique Protocol Identification Number
NCT04743167
Brief Title
IVF Versus Surgery for Endometriosis Related Infertility
Acronym
SVIDOE
Official Title
IVF Versus Surgery for the Treatment of Infertility Associated to Ovarian and Deep Peritoneal Endometriosis
Study Type
Interventional

2. Study Status

Record Verification Date
March 2022
Overall Recruitment Status
Recruiting
Study Start Date
March 16, 2021 (Actual)
Primary Completion Date
April 30, 2024 (Anticipated)
Study Completion Date
January 31, 2025 (Anticipated)

3. Sponsor/Collaborators

Responsible Party, by Official Title
Sponsor
Name of the Sponsor
Fondazione IRCCS Ca' Granda, Ospedale Maggiore Policlinico
Collaborators
IRCCS San Raffaele, ASST Fatebenefratelli Sacco, Ministero della Salute, Italy

4. Oversight

Studies a U.S. FDA-regulated Drug Product
No
Studies a U.S. FDA-regulated Device Product
No
Data Monitoring Committee
Yes

5. Study Description

Brief Summary
The management of endometriosis-related infertility remains controversial. In particular, there is an equipoise for infertile women with endometriotic lesions detected at ultrasound. These women can be managed with either surgery or in vitro fertilization (IVF). The two approaches radically differ and they have never been compared with a randomized trial. As a consequence, affected women currently receive contrasting information and the mode of treatment substantially differ among centres, reflecting the local expertise of physicians rather than clinical needs. The present study aims at clarify whether IVF could be superior to surgery in infertile women with endometriotic lesions detected at ultrasound. This topic will be addressed comparing the two approaches in terms of effectiveness and cost-effectiveness. In addition, the study will disentangling whether the endometriosis-related systemic inflammatory mechanisms may have an impact on the quality of folliculogenesis and on IVF outcomes. This specific objective will be pursued through the characterization and analysis of circulating extracellular vesicles (EV)-immunologic, proteomic and miRNA signatures and measurement of steroid hormones in follicular fluid.
Detailed Description
Women accepting to enter the study will be randomized to either surgery and then natural pregnancy seeking or a program of three complete IVF cycles (i.e. three oocytes retrievals regardless of the number of embryo transfers performed). The initial time point will be the time of randomization. Women of both study groups will initiate treatment (surgery or IVF) in a shortest delay, maximum 3 months. Only live birth pregnancies and initiating within a 12-months period starting from this time point will be included in the primary outcome.

6. Conditions and Keywords

Primary Disease or Condition Being Studied in the Trial, or the Focus of the Study
Endometriosis
Keywords
IVF, surgery, endometriosis

7. Study Design

Primary Purpose
Treatment
Study Phase
Not Applicable
Interventional Study Model
Parallel Assignment
Masking
None (Open Label)
Allocation
Randomized
Enrollment
206 (Anticipated)

8. Arms, Groups, and Interventions

Arm Title
Surgery
Arm Type
Active Comparator
Arm Description
Patients undergoing surgery for endometriosis, after surgery, will receive indications for seeking for a natural pregnancy up to 12 months from the time of randomization
Arm Title
In Vitro Fertilization
Arm Type
Active Comparator
Arm Description
Patients included in the IVF arm will undergo three complete cycles of IVF (i.e. three oocytes retrievals regardless of the number of embryo transfers)
Intervention Type
Procedure
Intervention Name(s)
Surgery
Intervention Description
Laparoscopic treatment of endometriotic lesions
Intervention Type
Procedure
Intervention Name(s)
IVF
Intervention Description
Up to three completed cycles of IVF
Primary Outcome Measure Information:
Title
Live birth rate from pregnancies started within 12 months since randomization
Description
to assess whether IVF is more effective than surgery in obtaining a live birth and, if so, what is the magnitude of this benefit
Time Frame
up to 12 months since randomization
Secondary Outcome Measure Information:
Title
Cost-effectiveness evaluation of the two different approaches in the treatment of endometriosis
Description
to assess whether or not IVF is more cost-effective than surgery. To this aim, costs will be calculated based on the local charges for treatments (Diagnostic-related groups) and the costs of drugs supported by the public health system. The perspective will be the one of the public health provider.
Time Frame
12 months
Title
Detachment of inflammatory mediators that might interfere with IVF through analysis of extracellular vescicles (EV).
Description
to understand whether the endometriosis-related systemic inflammatory milieu demonstrated by the presence of circulating EVs characterized by an inflammatory signature may influence the folliculogenesis quality and IVF outcomes. EVs will be assessed by: Nanoparticle Tracking analysis (NTA) to determine their total values and their distribution; specific markers for the various lymphocyte populations by flow cytometry to assess the immunological origin; miRNA profile and proteomic analysis.
Time Frame
3 months

10. Eligibility

Sex
Female
Minimum Age & Unit of Time
18 Years
Maximum Age & Unit of Time
39 Years
Accepts Healthy Volunteers
No
Eligibility Criteria
Inclusion Criteria: Age < 40 years Pregnancy seeking for more than 12 months Regular menstrual cycle, i.e. mean cycle interval between 21 and 35 days Ultrasonographic diagnosis of ovarian endometriomas or deep peritoneal endometriosis. Normal seminal analysis based on WHO criteria Absence of ureteral stenosis or intestinal subocclusive symptoms Exclusion Criteria: Previous surgery for endometriosis Previous IVF cycles Contraindication to pregnancy Hydrosalpinx Endometriomas with a mean diameter > 4 cm Submucosal fibroids or large intramural or subserosal fibroids (≥ 5 cm). Doubtful sonographic findings that do not allow to reliably rule out malignancy. Obstacles to regular sexual intercourses (sexual disturbances or logistic problems)
Central Contact Person:
First Name & Middle Initial & Last Name or Official Title & Degree
Laura Benaglia, MD
Phone
+390255034303
Email
laura.benaglia@policlinico.mi.it
First Name & Middle Initial & Last Name or Official Title & Degree
Marco Reschini, MSc
Phone
+390255034303
Email
marco.reschini@policlinico.mi.it
Overall Study Officials:
First Name & Middle Initial & Last Name & Degree
Laura Benaglia, MD
Organizational Affiliation
Fondazione IRCCS Ca' Granda, Ospedale Maggiore Policlinico
Official's Role
Principal Investigator
Facility Information:
Facility Name
ASST-FBF-Sacco, Presidio Ospedaliero Macedonio Melloni
City
Milan
State/Province
MI
ZIP/Postal Code
20100
Country
Italy
Individual Site Status
Recruiting
Facility Contact:
First Name & Middle Initial & Last Name & Degree
Michele Vignali, MD
Facility Name
IRCCS San Raffaele
City
Milan
State/Province
MI
ZIP/Postal Code
20100
Country
Italy
Individual Site Status
Recruiting
Facility Contact:
First Name & Middle Initial & Last Name & Degree
Jessica Ottolina, MD
Facility Name
Fondazione IRCCS Ca' Granda Ospedale Maggiore Policlinico
City
Milan
State/Province
MI
ZIP/Postal Code
20122
Country
Italy
Individual Site Status
Recruiting
Facility Contact:
First Name & Middle Initial & Last Name & Degree
Laura Benaglia, MD
Phone
+390255034303
Email
laura.benaglia@policlinico.mi.it

12. IPD Sharing Statement

Plan to Share IPD
No
Citations:
PubMed Identifier
35921357
Citation
Ottolina J, Vignali M, Papaleo E, Vigano P, Somigliana E, Ferrari S, Liprandi V, Belloni G, Reschini M, Candiani M, Vercellini P, Benaglia L. Surgery versus IVF for the treatment of infertility associated to ovarian and deep endometriosis (SVIDOE: Surgery Versus IVF for Deep and Ovarian Endometriosis). Clinical protocol for a multicenter randomized controlled trial. PLoS One. 2022 Aug 3;17(8):e0271173. doi: 10.1371/journal.pone.0271173. eCollection 2022.
Results Reference
derived

Learn more about this trial

IVF Versus Surgery for Endometriosis Related Infertility

We'll reach out to this number within 24 hrs